Initial public offer of up to [*] equity shares of face value of Rs.2/- each ("equity shares") of Manipal Health Enterprises Limited ("company" or "issuer") for cash at a price of Rs.[*] per equity share (including a share premium of Rs.[*] per equity share) ("offer price") aggregating up to Rs.[*] crores comprising a fresh issue of up to [*] equity shares of face value of Rs.2/- each aggregating up to Rs.8000.00 crores by the company ("fresh issue") and an offer for sale of up to 43,227,668 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by the selling shareholders, comprising an offer for sale of up to 21,617,723 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Imperius Healthcare Investments Pte. Ltd., (the "promoter selling shareholder"), up to 13,584,004 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Manipal Education and Medical Group India Private Limited (the "promoter group selling shareholder"), up to 4,659,335 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by TPG SG Magazine Pte. Ltd., up to 1,584,987 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Seventy Second Investment Company LLC, up to 811,582 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Ammar SDN BHD, up to 529,111 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Novo Holdings Invest Asia A/S, and up to 440,926 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Phoenix Bear Investments, LLC, (collectively the "investor selling shareholders") (the promoter selling shareholder, the promoter group selling shareholder and the investor selling shareholders collectively referred to as the "selling shareholders" and such equity shares offered by the selling shareholders ("offered shares") and such offer, "offer for sale", and together with the fresh issue, the "offer").
The company, in consultation with the brlms, may consider a pre-ipo placement of equity shares, as may be permitted under applicable law, at its discretion, aggregating up to Rs.1600.00 crores prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (regulation) Rules, 1957, as Amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. The utilisation of the proceeds raised pursuant to the pre-ipo placement will be done towards the proposed objects of the offer in compliance with applicable law. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken).
The face value of equity shares is Rs.2/- each. The offer price is [*] times the face value of the equity shares.
The price band and the minimum bid lot will be decided by the company.